Control of urge incontinence

• US 7,582,053 B2
• Filed: 09/24/2003
• Issued: 09/01/2009
• Est. Priority Date: 10/06/1998
• Status: Expired due to Fees

• Current Assignee: ASTORA Women's Health, LLC (Endo International PLC)
• Original Assignee: Ams Research Corporation (Endo International PLC)
• Inventors: Lifschitz, David, Nissenkorn, Israel, Cohen, Ehud, Gross, Yossi
• Primary Examiner(s): Lacyk; John P
• Application Number:
  US10/671,144
• Publication Number:
  US 20050261746A1
• Time in Patent Office: 2,169 Days
• Field of Search: 600 29- 32, 600/549, 600/551, 600/591, 128/DIG.25, 607 70- 72, 607/61, 607/41, 607/138
• US Class Current: 600/30
• CPC Class Codes: A61F 2/0036 implantable A61F2/0018 takes precedence
• CPC Class Codes: A61F 2250/0001 Means for transferring electromagnetic energy to implants

Abstract

A device (20) for treatment of a patient'"'"'s urinary incontinence, including a sensor, (44), which generates a signal responsive to a physiological characteristic indicative of a likelihood of incontinence. A control unit (22) receives the signal from the sensor. At least one electrode (29) is preferably implanted in the patient. The electrode is coupled to cause contraction of a pelvic muscle of the patient responsive to application of electrical energy to the electrode. Responsive to the signal, the control unit applies an electrical waveform to the electrode, so as to inhibit the incontinence.

Claims

1. A method comprising:

implanting at least one electrode in a patient in contact with a pelvic muscle of the patient;

implanting a stimulator device in the patient; and

driving the at least one electrode to apply a biphasic electrical waveform to the muscle using the stimulator device.

2. The method according to claim 1, wherein implanting the at least one electrode comprises implanting the at least one electrode in the pelvic muscle.

3. The method according to claim 1, further comprising contracting the pelvic muscle in response to driving the at least one electrode, wherein urine flow through a urethra of the patient is inhibited.

4. The method according to claim 3, wherein driving the at least one electrode comprises configuring the waveform to treat urinary urge incontinence.

5. The method according to claim 3, wherein driving the at least one electrode comprises configuring the waveform to treat stress incontinence.

6. A method comprising:

implanting at least one elongated electrode structure in contact with a pelvic muscle of the patient;

implanting a stimulator device in the patient;

driving the at least one electrode to apply an electrical waveform to the muscle using the stimulator device;

providing for the electrical waveform a plurality of pulses each having pulse width duration of 2 ms or less; and

contracting the pelvic muscle in response to driving the at least one electrode, wherein urine flow through the urethra of the patient is inhibited.

7. The method according to claim 6, wherein implanting the at least one electrode comprises implanting the at least one electrode in the pelvic muscle.

8. The method according to claim 6, wherein providing for the electrical waveform comprises setting the pulse width durations of the pulses within a range of 0.1 ms to 2 ms.

9. The method according to claim 6, wherein the plurality of pulses each have a pulse width duration of less than 1 ms.

10. The method according to claim 6, wherein driving the at least one electrode comprises configuring the waveform to treat urinary urge incontinence.

11. The method according to claim 6, wherein driving the at least one electrode comprises configuring the waveform to treat stress incontinence.

12. The method according to claim 6, wherein the pelvic muscle includes the levator ani muscle, and wherein implanting the at least one electrode comprises implanting the at least one electrode in the levator ani muscle.

13. The method according to claim 6, wherein the pelvic muscle includes the urethral sphincter muscle, and wherein implanting the at least one electrode comprises implanting the at least one electrode in the urethral sphincter muscle.

14. The method according to claim 6, further comprising terminating application of the waveform to the muscle after a predetermined period of time.

15. The method according to claim 14, wherein the predetermined period of time is about 5 seconds.

16. The method according to claim 14, wherein driving the at least one electrode comprises driving the at least one electrode to reapply the waveform after termination of the application of the waveform.

17. The method according to claim 6, wherein driving the at least one electrode comprises providing for the waveform a biphasic electrical waveform.